🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Aldesleukin may stimulate the white blood cells to kill tumor ce...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2008-06
Trial ID
NCT00726739
Treatments Being Tested
The purpose of this research study is to see if the combination of HSPPC-96...
Status
Withdrawn
Location
UTHealth Memorial Hermann Cancer Center
Start Date
2015-12
Trial ID
NCT02452281
Treatments Being Tested
The purpose of this study is to find out what effects (good and bad) immuno...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-03-15
Trial ID
NCT03406715
Treatments Being Tested
Current therapeutic approaches available for patients with advanced-stage m...
Status
Completed
Location
Hillman Cancer Center
Start Date
2014-05-16
Trial ID
NCT01876212
Treatments Being Tested
This phase I trial studies the safety of personalized neo-antigen peptide v...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-06-09
Trial ID
NCT05098210
Objectives: The primary objective will be to determine whether patients re...
Status
Active Not Recruiting
Location
The University of Texas MD Anderson Cancer Center
Start Date
2006-02-01
Trial ID
NCT00338377
The goal of this clinical research study is to find the best dosing schedul...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2009-03-10
Trial ID
NCT00861406
Treatments Being Tested
The purpose of this study is to determine what side effects CP 870,893 may ...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2009-10
Trial ID
NCT01008527
Treatments Being Tested
This research study is investigating a new type of personalized neoantigen ...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2020-11-11
Trial ID
NCT03929029
Treatments Being Tested
This is an open-label, phase II study of a vaccine comprising melanoma pept...
Status
Completed
Location
University of Virginia
Start Date
2000-08
Trial ID
NCT00938223
Treatments Being Tested